The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC)
Jordi Bruix
Consultant or Advisory Role - ArQule; Bayer; Biocompatibles; Bristol-Myers Squibb; Daiichi Sankyo; Novartis; Roche
Honoraria - Bayer; Biocompatibles; Bristol-Myers Squibb; Novartis
Research Funding - ArQule; Bayer; Daiichi Sankyo
Tadatoshi Takayama
No relevant relationships to disclose
Vincenzo Mazzaferro
No relevant relationships to disclose
Gar-Yang Chau
Research Funding - Bayer
Jiamei Yang
No relevant relationships to disclose
Masatoshi Kudo
No relevant relationships to disclose
Jianqiang Cai
No relevant relationships to disclose
Ronnie Tung-Ping Poon
No relevant relationships to disclose
Kwang-Hyub Han
No relevant relationships to disclose
Won-Young Tak
No relevant relationships to disclose
Han Chu Lee
Research Funding - Bayer
Tianqiang Song
No relevant relationships to disclose
Sasan Roayaie
No relevant relationships to disclose
Luigi Bolondi
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Sirtex Medical
Honoraria - Bayer; Bristol-Myers Squibb; Sirtex Medical
Research Funding - Bayer; Bristol-Myers Squibb
Kwan Sik Lee
No relevant relationships to disclose
Masatoshi Makuuchi
No relevant relationships to disclose
Fabricio Souza
Employment or Leadership Position - Bayer
Marie-Aude Le Berre
Employment or Leadership Position - Bayer
Gerold Meinhardt
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Josep M. Llovet
Consultant or Advisory Role - Bayer; BioSphere Medical; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; NanoString Technologies
Honoraria - Bayer; Bristol-Myers Squibb; Lilly; NanoString Technologies
Research Funding - Bayer; Boehringer Ingelheim